Literature DB >> 17510564

Evaluation of CD31 (PECAM-1) expression using tissue microarray in patients with renal cell carcinoma.

Johanna Sandlund1, Ylva Hedberg, Anders Bergh, Kjell Grankvist, Börje Ljungberg, Torgny Rasmuson.   

Abstract

Intratumoural microvessel density (MVD) has prognostic significance in selected neoplasms. To evaluate the prognostic information of MVD in renal cell carcinoma (RCC) we assessed the immunohistochemical expression of CD31 in 208 tumours using the tissue microarray technique. The expression was related to tumour cell type, TNM stage, nuclear grade and survival. CD31 expression was significantly (p < 0.001) higher in 167 conventional RCCs (clear cell) compared to 28 papillary RCCs. In conventional RCC, CD31 expression was inversely correlated to TNM stage (p = 0.024) and nuclear grade (p = 0.010). To evaluate the impact of CD31 expression on tumour-specific survival, the conventional RCC tumours were subdivided into quartiles according to the CD31 expression. In univariate analysis, patients with tumours in the quartile with the highest expression had a more favourable prognosis (p = 0.01) compared to those with lower CD31 expression. A multivariate analysis of prognostic factors in conventional RCC showed that TNM stage and nuclear grade were independent predictors of prognosis, but CD31 expression did not add further prognostic information. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17510564     DOI: 10.1159/000102980

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  11 in total

1.  Quantification of diverse subcellular immunohistochemical markers with clinicobiological relevancies: validation of a new computer-assisted image analysis procedure.

Authors:  Marylène Lejeune; Joaquín Jaén; Lluis Pons; Carlos López; Maria-Teresa Salvadó; Ramón Bosch; Marcial García; Patricia Escrivà; Jordi Baucells; Xavier Cugat; Tomás Alvaro
Journal:  J Anat       Date:  2008-06       Impact factor: 2.610

2.  Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805.

Authors:  Lucia B Jilaveanu; Maneka Puligandla; Sarah A Weiss; Xin Victoria Wang; Christopher Zito; Keith T Flaherty; Marta Boeke; Veronique Neumeister; Robert L Camp; Adebowale Adeniran; Michael Pins; Judith Manola; Robert S DiPaola; Naomi B Haas; Harriet M Kluger
Journal:  Clin Cancer Res       Date:  2017-10-24       Impact factor: 12.531

3.  The vascular landscape of human cancer.

Authors:  Benjamin M Kahn; Alfredo Lucas; Rohan G Alur; Maximillian D Wengyn; Gregory W Schwartz; Jinyang Li; Kathryn Sun; H Carlo Maurer; Kenneth P Olive; Robert B Faryabi; Ben Z Stanger
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

4.  Vascular architectural patterns in clear cell renal cell carcinoma and clear cell papillary renal cell carcinoma.

Authors:  Sofia Canete-Portillo; Maria Del Carmen Rodriguez Pena; Dezhi Wang; Diego F Sanchez; George J Netto; Cristina Magi-Galluzzi
Journal:  Virchows Arch       Date:  2021-10-05       Impact factor: 4.064

5.  Microvessel density and heparanase over-expression in clear cell renal cell cancer: correlations and prognostic significances.

Authors:  Juchao Ren; Hainan Liu; Lei Yan; Sujian Tian; Dawei Li; Zhonghua Xu
Journal:  World J Surg Oncol       Date:  2011-12-02       Impact factor: 2.754

6.  Pulmonary Lymphangitic Carcinomatosis due to Renal Cell Carcinoma.

Authors:  Achuta K Guddati; Creticus P Marak
Journal:  Case Rep Oncol       Date:  2012-05-15

7.  Development and Validation of a Histological Method to Measure Microvessel Density in Whole-Slide Images of Cancer Tissue.

Authors:  Koen M Marien; Valerie Croons; Yannick Waumans; Ellen Sluydts; Stefanie De Schepper; Luc Andries; Wim Waelput; Erik Fransen; Peter B Vermeulen; Mark M Kockx; Guido R Y De Meyer
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

8.  Cell aggregation induces phosphorylation of PECAM-1 and Pyk2 and promotes tumor cell anchorage-independent growth.

Authors:  Xing Zhang; Li-hua Xu; Qiang Yu
Journal:  Mol Cancer       Date:  2010-01-14       Impact factor: 27.401

9.  Analyses of potential predictive markers and survival data for a response to sunitinib in patients with metastatic renal cell carcinoma.

Authors:  Juana Dornbusch; Aristeidis Zacharis; Matthias Meinhardt; Kati Erdmann; Ingmar Wolff; Michael Froehner; Manfred P Wirth; Stefan Zastrow; Susanne Fuessel
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

10.  Stage-dependent prognostic impact of molecular signatures in clear cell renal cell carcinoma.

Authors:  Thomas Weber; Matthias Meinhardt; Stefan Zastrow; Andreas Wienke; Kati Erdmann; Jörg Hofmann; Susanne Fuessel; Manfred P Wirth
Journal:  Onco Targets Ther       Date:  2014-05-02       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.